AVCJ - March 24 2020
Features of the AVCJ March 24 2020 issue: COVID-19 & leverage: Time to renegotiate Funds: Why 8F is targeting sustainable salmon COVID-19 & secondaries: Asia at a standstill GP Profile: China healthcare...
More on Region
Latest News
Warburg Pincus leads Series C for China AI drug developer
Insilico Medicine, which leverages artificial intelligence (AI) technology to speed up the drug development process, has closed a $255 million Series C funding round led by Warburg Pincus.
PE investors agree $5.7b 51job take-private
A consortium led by DCP Capital Partners has finalized terms for a $5.7 billion privatization of US-listed Chinese online recruitment platform 51job.
Chinese drug developer Abbisko files for HK IPO
PE-backed Abbisko Therapeutics, which focuses on the discovery and development of innovative and differentiated small molecule oncology therapies, has filed for a Hong Kong IPO.